SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-666694
Filing Date
2016-08-01
Accepted
2016-08-01 16:42:51
Documents
53
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d216255d10q.htm 10-Q 636142
2 EX-31.1 d216255dex311.htm EX-31.1 8428
3 EX-31.2 d216255dex312.htm EX-31.2 8424
4 EX-32.1 d216255dex321.htm EX-32.1 4917
  Complete submission text file 0001193125-16-666694.txt   3108106

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sbph-20160630.xml EX-101.INS 441421
6 XBRL TAXONOMY EXTENSION SCHEMA sbph-20160630.xsd EX-101.SCH 34385
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbph-20160630_cal.xml EX-101.CAL 45177
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbph-20160630_def.xml EX-101.DEF 148427
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbph-20160630_lab.xml EX-101.LAB 307671
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbph-20160630_pre.xml EX-101.PRE 226482
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37718 | Film No.: 161797829
SIC: 2834 Pharmaceutical Preparations